Oracle is scheduled to report fiscal fourth-quarter earnings after the closing bell Wednesday, with analysts watching for ...

Core Natural Resources initiated with Buy rating at UBS, which sees positive stock specific catalysts over the next 6-12 ...

Chipmaker Broadcom is set to report quarterly results after the closing bell Thursday, with Wall Street analysts expecting ...

TipRanks' analyst ranking service highlights three stocks, including Nvidia and Salesforce, favored by Wall Street's top pros ...

22 analysts have expressed a variety of opinions on Datadog DDOG over the past quarter, offering a diverse set of opinions ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $48.97, ...

BMO Capital Markets is highlighting the advantages of growth-at-a-reasonable-price ((GARP)) as a smart investment strategy, ...

Dividend stocks are one way to shield yourself from the market volatility. While all stocks carry a certain element of risk, ...

Insmed Incorporated (NASDAQ: INSM) is among the 13 Biotech Stocks with Huge Upside Potential. Kelly Shi of Jefferies has given Insmed Incorporated (NASDAQ:INSM) a buy recommendation, stating that she ...

TipRanks’ analyst ranking service discusses three dividend-paying stocks, including Home Depot and Diamondback Energy, ...

We have crunched the numbers and here is our best estimates about Amazon’s share price through the rest of the decade.

Citi analysts reiterated a Buy rating on Gilead Sciences, Inc. (NASDAQ:GILD) stock and maintained a $125 price target.